Dr Greg Arndt
DRUG DISCOVERY CENTRE MANAGER
MSc (UofS), PhD (Biol) (UofS);
Dr Greg Arndt joined Children's Cancer Institute in 2008 to establish the ACRF Drug Discovery Centre for Childhood Cancer. He received his PhD from the University of Saskatchewan, Canada in 1993 and worked as a postdoctoral fellow at the RW Johnson Pharmaceutical Research Institute. Prior to joining the institute, Dr Arndt was Research Director and Project Leader with Johnson & Johnson Research Pty Ltd, where he spent 15 years in increasingly senior roles focusing on cell-based screening as a tool for developing novel therapeutics.
Upon joining the DDC, Dr Arndt spent six months training at the Walter & Eliza Hall Institute of Medical Research (WEHI) to gain further experience with high throughput chemical screening in an academic setting. In addition to industry experience, Dr Arndt has also had significant academic involvement, being an Adjunct Senior Lecturer (2005–2007) and Senior Visiting Fellow (2007–2013) in the School of Biotechnology and Biomolecular Science, UNSW Australia. In this context, he has successfully trained several Honours and PhD students and published numerous manuscripts in high-quality journals. His research has also led to the submission of several international patent applications.